.jpg)
Bryan, Garnier & Co, the leading pan-European Investment Bank focusing on growth companies, is pleased to announce that Pierre Kiecolt-Wahl has joined the firm as Managing Director, ECM, where he will lead Bryan, Garnier & Co’s equity capital markets efforts throughout Europe.
“Over the past 15 years, Pierre has gained significant experience in advising innovative growth companies and investors in our core sectors of expertise, dealing with a wide variety of situations in more than twenty different markets across Europe, Asia and the US,” said Greg Revenu, Managing Partner and co-founder of the group. “He adds critical insight and equity capital market expertise to our firm, so we can further deliver for our clients. We are delighted he has decided to join the team.”
An American/French citizen, Pierre brings more than 15 years of international equity capital markets knowledge with organizations such as Bank of America, Lehman Brothers, Jefferies and Citi, based in San Francisco, London and Hong Kong.
significant number in the biotech and pharma sectors, including IPOs and follow-ons for Algeta, Almirall, Alapis, Bavarian Nordic, Cosmo Pharma, Medivir, Molmed, Thrombogenics, and Zealand Pharma (with Bryan Garnier), as well as in TMT and consumer including offerings for Tele Atlas, Cineworld, and Ocado, amongst others.
“Bryan Garnier has one of the leading ECM franchises and in particular, has a unique track record of successfully raising capital for innovative European growth companies across both the European and US markets.
The strength of its pan-European growth focused equity research and the firm's ability to access leading investors in both Europe and the US makes Bryan Garnier a highly differentiated investment bank in Europe.
Combined with the firm’s focus on the most successful European growth companies and delivering for its clients, the Bryan Garnier platform is extremely compelling and I am very pleased to be joining. I look forward to leveraging my experience and relationships in support of the continued success of our clients and the firm,” Mr. Kiecolt-Wahl said.
